FILE PHOTO: Chinese fax manufacturer CanSino Biologics’ sign is pictured at its building in Tianjin, China November 20, 2018. Image taken November 20, 2018. REUTERS / Stringer BEIJING (Reuters) – Chinese vaccine specialist CanSino Biologics Inc has won a patent judgment from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state …
Read More »China loses first COVID-19 vaccine patent to CanSino: state media
